Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 135 (5), 888-896
- https://doi.org/10.1016/j.thromres.2015.02.032
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A graphical tool for locating inconsistency in network meta-analysesBMC Medical Research Methodology, 2013
- Apixaban for Extended Treatment of Venous ThromboembolismNew England Journal of Medicine, 2013
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous ThromboembolismNew England Journal of Medicine, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2Value in Health, 2011
- Oral Rivaroxaban for Symptomatic Venous ThromboembolismNew England Journal of Medicine, 2010
- Extended Prophylaxis of Venous Thromboembolism with IdraparinuxNew England Journal of Medicine, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous ThrombosisNew England Journal of Medicine, 2001
- A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous ThromboembolismNew England Journal of Medicine, 1999